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Stereotactic excisional biopsy in nonpalpable breast lesions
using the Advanced Breast Biopsy Instrumentation (ABBI) system
Zbigniew Mentrak, Janusz JaÊkiewicz, Jerzy Pietruszkiewicz, Ewa Weso∏owska
I n t r o d u c t i o n. The purpose of our study was to analyze the usefulness of the ABBI system as a diagnostic and therapeu-
tic procedure in nonpalpable breast lesions.
M a t e r i a l  a n d  m e t h o d. Since 1998, 93 patients have been qualified for the ABBI procedure. In 67% of cases the proce-
dure was indicated due to a cluster of microcalcifications, and in 33% – due to the presence of a tumor. The operation was per-
formed under local anaesthesia on an autpatient basis.
R e s u l t s .  18 lesions were found to be malignant and 61 – benign. All the patients with malignant lesions underwent
adequate oncological treatment, while patients with benign lesions remained under follow-up control. In three cases of ma-
lignant lesions the procedure was regionally curative.
D i s c u s s i o n . We conclude that, in view of the increasing number of early-diagnosed nonpalpable breast lesions,
the diagnostic methods used until now do not seem satisfactory. The ABBI system is effective and appears to be 
promising for the diagnosis and treatment of nonpalpable breast lesions. What is more – in selected cases it may be regional-
ly curative.
C o n c l u s i o n s. The ABBI procedure is a supplementary diagnostic tool used in case of nonpalpable breast lesions. The ABBI
procedure is initially, diagnostic, but in selected cases it may be regionally curative.
Stereotaktyczna biopsja wycinajàca przy u˝yciu systemu ABBI
w diagnostyce i leczeniu niepalpacyjnych zmian piersi u kobiet
W s t ´ p. Celem pracy jest ocena przydatnoÊci aparatu „ABBI” (z ang. Advanced Breast Biopsy Instrumentation) w diagno-
styce i leczeniu niepalpacyjnych zmian piersi u kobiet w materiale Kliniki Nowotworów Sutka Centrum Onkologii-Instytutu
w Warszawie.
M a t e r i a ∏  i m e t o d a. W latach 1998-1999 zanalizowano grup´ 93 kobiet wst´pnie zakwalifikowanych do zabiegu.
W 67% przypadków wskazaniami by∏o skupisko mikrozwapnieƒ, a w 33% guzek gruczo∏u piersiowego. Zabieg wykonywany
by∏ w warunkach sali zabiegowej kliniki w znieczuleniu miejscowym.
W y n i k i. Stwierdzono 18 zmian z∏oÊliwych i 61 ∏agodnych. We wszystkich przypadkach raka sutka wdro˝ono dalsze leczeni;
pacjentki ze zmianami ∏agodnymi pozostawa∏y pod okresowà kontrolà. W trzech przypadkach zmian z∏oÊliwych zabieg by∏ miej-
scowo radykalny.
D y s k u s j a . Po wst´pnej ocenie wydaje si´, ˝e wobec narastajàcego problemu wykrywanych wczeÊnie subklinicznych
zmian gruczo∏u piersiowego dotychczas stosowana diagnostyka nie jest w pe∏ni wystarczajàca. Aparat ABBI jest 
cennym urzàdzeniem w diagnostyce ww. zmian piersi, w wyselekcjonowanych przypadkach zabieg mo˝e byç
terapeutyczny.
W n i o s k i . Aparat ABBI jest cennym uzupe∏nieniem dotychczas stosowanych metod diagnostycznych niepalpacyjnych
zmian gruczo∏u piersiowego u kobiet. Jest to zabieg diagnostyczny, ale w szczególnych sytuacjach mo˝e spe∏niaç warunki za-
biegu miejscowo terapeutycznego.
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Introduction
Breast cancer is the most frequent oncological malignan-
cy in women. Approx. 9500 new cases were recorded
in year 1998 in Poland, while mortality reached approx.
4000 cases. The recent years brought the development
of early detection of breast cancer– new programs of bre-
ast cancer screening are being introduced. As a result of
these activities there is a growing problem of the diagno-
stis of nonpalpable breast lesions. A majority of these le-
sions appear either in the form of suspicious clusters
of microcalcifications or of the disturbances of breast ar-
chitecture. We undertake diagnostic procedures in case
of lesions classified as 3 to 5 acc. to BIRAD classification
[1-3].
Diagnostic methods used until now – such as core
biopsy, fine needle aspiration or open surgical biopsy –
are not considered sufficient [4-6]. In cases of positive
or nondiagnostic results open surgical biopsy performed
under general anaesthesia is required. This requires a ho-
spitalisation period of two days and, often, the necessity of
preparing elderly patients, suffering from coexisting
diseases, for general anaesthesia, thus raising the costs
and possible complications of the procedure.
Since 1997, the ABBI procedure has been frequently
applied in leading oncological centers. Combined with
the VAB, the ABBI system fills the gap in diagnostic pro-
cedures of nonpalpable breast lesions.
Materials and methods
Between 1998n and 1999 93 women with nonpalpable breast
lesions were qualified for excisional stereotactic biopsy using
the ABBI system. In 63 cases (67%) the indication for the proce-
dure was a cluster of microcalcifications, while in 30 cases (33%)
- the presence of a tumor or architectural disturbances of breast
tissue. At the onset of the study, we qualified all lesions pronoun-
ced as slightly suspected in radiological examination. Lesions
pronounced to be cancer were not qualified.
The ABBI system was installed in our Department of
Breast Cancer within the treatment room (Fig. 1). The room
itself did not need any serious adaptations, regarding the we-
ight nor the dimensions of the apparatus, nor  regarding ra-
diobiological protection. The first ABBI procedures were per-
formed under the supervision of trained staff from the United
States.
Two persons are required to perform the ABBI procedure
– a surgeon and a trained nurse assistant. The patient is placed
on a special table and the breast is positioned in a fixative arm.
The procedure consists of two steps. Initially, two stereo images
are taken to localise the lesion under digital mammography
(±15 degrees). Computed analysis allows to obtain a precise
image of the lesion on screen, regarding its position (including its
depth in breast tissue) in all three planes (X,Y,Z). In the se-
cond, having performed local anaesthesia with lidocaine 1%
(with adrenaline) a wire needle is inserted in to the breast thro-
ugh a small (2 mm) skin incision. Another digital mammography
picture is taken; the incision is then widened to approx. 3 cm and
an oscillating operating knife is inserted to remove the lesion. At
the tip of the operating knife there is the coagulating loop,
which may be opened to remove the entire specimen. Haemosta-
sis, skin sutures and elastic dressing of the breast complete the
procedure.
Results
In 61 of the 79 women undergoing the ABBI procedure,
the lesion was benign. The most frequent diagnosis was
focal dysplasia – 37 cases (60%), fibroma – 16 cases
(26%), and „radial scar” – 8 cases (14%). All these wo-
men are followed up by our outpatient clinic. Mammogra-
phy of the treated breast is performed 6 months after the
ABBI procedure.
In the remaining 18 cases the lesions were found to
be malignant. There were 11 cases of DCIS and 7 cases of
invasive carcinoma of the breast. All these women un-
derwent adequate oncological treatment. In three cases of
DCIS the only treatment required was radiotherapy (satis-
factory healthy tissue margins around the lesion). The
remaining patients (with either CDIS or invasive cancer)
underwent surgery – modified radical mastectomy, simple
mastectomy or breast conserving treatment was perfor-
med depending upon the technical possibilities and the
preferences expressed by the patient.
At the introduction of the ABBI procedure we found
the localisation of the lesion to be the most difficult pha-
se; the adequate use of the operating arm also caused
some difficulty. Nowadays, the procedure lasts less than
15–20 minutes. The operating phase and the treatment of
the wound last no more than 10 to 15 minutes.
Among the 93 women who were qualified for ABBI
diagnostics, in 14 cases we did not manage to complete
the procedure. In eight cases the lesion was situated too
close to the chest wall. In two cases it was located too
high within the upper external quadrant of the breast.
Both the latter and the former situation cause a high risk
of chest wall damage. In four cases, despite taking serial
mammographic images of the suspected region of the
breast we did not manage to locate the lesion. In all the-
se cases open surgical excisional biopsies were perfor-
med.
We did not observe any intraoperative complica-
tions. In two cases we observed postoperative haematoma
of the wound – not requiring surgical treatment. In one
case local infection of the wound was observed several
days after the intervention, and was satisfactorily treated
with an antibiotic.
Fig. 1. The ABBI operating table
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Discussion
Considering the fact that the number of nonpalpable bre-
ast lesions is growing there is a need for an effective tool
for their diagnosis. More DCIS are being detected. Mam-
mographically they are usually manifested as clusters of
microcalcifications. This eliminates fine needle aspira-
tion biopsy under ultrasound. Core biopsy under\ mam-
mography allows to diagnose the lesion, but does not of-
fer the possibility of curative treatment. The patient has to
be operated yet again [6, 7, 8]. Severe problems arise in
patients not fit for general anaesthesia The localisation
and excised under local anaesthesia, but it may not al-
ways be possible.
In selected cases the ABBI system may be used as
a diagnostic tool and, at the same time, be regionally cu-
rative [9, 10, 11]. In our material the ABBI procedure
was regionally radical in three cases of DCIS. The histolo-
gical reports of these three patients revealed that there
was a satisfactory margin of healthy breast tissue around
the malignant lesions. These patients underwent radiothe-
rapy alone [12, 8].
The ABBI procedure is well tolerated. In literature
one may find a list of contraindications to ABBI such as:
body weight above 130 kg., degenerative disorders of the
pectoral spine or circulatory disorders which do not allow
the patient to remain in a prone position for approx. 40
minutes.
The procedure itself is safe, practically no complica-
tions are observed during the procedure. The cosmetic ef-
fect of the scar is judged to be very good [13, 14].
The ABBI system is expensive. However, in the Uni-
ted States the ABBI procedure is two to three times
cheaper than open surgical biopsy.
Conclusions
1. The ABBI is an effective tool in the management of
suspicious nonpalpable breast lesions.
2. The ABBI is a diagnostic procedure, but in a selec-
ted cases it may be regionally curative.
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